Previously, we have demonstrated that PBMC from weight-losing pancreatic cancer patients control the hepatic APPR by a primarily IL-6-dependent mechanism (O'Riordain et al, 1999). This evidence concerns the gene IL6 and familial pancreatic carcinoma.